Cogent Biosciences, Inc. (COGT)
37.25
+1.06
(+2.93%)
USD |
NASDAQ |
Apr 17, 16:00
36.53
-0.72
(-1.93%)
After-Hours: 05:22
Cogent Biosciences SG&A Expense (Quarterly) : 23.93M for Dec. 31, 2025
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Syndax Pharmaceuticals, Inc. | 49.93M |
| Vera Therapeutics, Inc. | 34.90M |
| Terns Pharmaceuticals, Inc. | 8.699M |
| Nuvalent, Inc. | 34.43M |
| Insmed, Inc. | 212.48M |